en
/
fr
Ethics Portal
Who We Are
Vision & Mission
Our Model
Strategy
Governance & Team
Governance Board
Expert Advisory Group
MPP Staff (A to Z)
Ethics Portal
Funding
Who We Work With
What We Do
Our Work
HIV
Hepatitis C
Tuberculosis
Paediatrics
Licence Overview
Products Licensed
Key features of MPP licences
Update on Progress
Other Partnerships
Expression of Interest
Projections
Projections Tool
Target Medicines
Media
Endorsements
Press
Press Kit
Press Releases
Statements
Highlights
Features
Message from the Executive Director
‘First Person’ series
Dolutegravir – making a difference to people’s lives
MPP in the News
Events
Resources
MedsPaL
Q&A on MedsPaL
Publications
Annual Reports
MPP Publications
Related Publications
Projections
Multimedia
Newsletters
Glossary
Documents
Resources Search
Contact
Resources Search
Newsletter
11 May 2011
May 2011 Newsletter
MPP Publications
01 April 2011
MPP: Comments to the US Patent and Trademark Office
Related Publication
20 November 2001
WTO: Doha Declaration on the TRIPS agreement and public health
« Previous
1
…
10
11
12
Keywords
Resource Type
All
Annual Reports
Document
MPP Publications
Newsletter
Projections
Publication
Related Publication
Disease
All
Hepatitis C
HIV
TB
Search
Cookie Policy
This website uses cookies to ensure you get the best experience on our website.
Learn More
Decline
Allow Cookies
Newsletter 
MPP Publications 